JKSE
JKSE
HDIT vs HEAL — which is the better stock?
Hensel Davest Indonesia Tbk. (HDIT) compared against Medikaloka Hermina Tbk. (HEAL). Data through 2026-08-21.
HDIT
JKSEHensel Davest Indonesia Tbk.
| Last close | 50 |
| 1Y return | +4.17% |
| 3Y return | 0.00% |
| 5Y return | -88.04% |
| P/E ratio | — coming soon |
| Dividend yield | — coming soon |
| Sector | JKSE |
| Data since | 2019-07-12 |
HEAL
JKSEMedikaloka Hermina Tbk.
| Last close | 665 |
| 1Y return | -60.42% |
| 3Y return | -52.67% |
| 5Y return | -41.41% |
| P/E ratio | — coming soon |
| Dividend yield | — coming soon |
| Sector | JKSE |
| Data since | 2018-05-17 |
Shared price chart (normalized to 100)
Loading chart…
Both series are normalized to 100 at the start of the selected range so absolute price differences don't dominate the comparison.
Why compare HDIT vs HEAL?
HDIT and HEAL are both JKSE-listed stocks that often come up together when investors weigh Indonesian equity exposure. Looking at them side by side — last close, 1Y/3Y/5Y returns, and sector tag — makes it easier to pick the one that matches your portfolio's thesis. The shared chart above re-bases both tickers to 100 at the start of the range so the slope of each line directly answers "which one grew faster?".